Smokefree’s clinical and drug content is medically reviewed by our team of medical professionals and fact-checked by professional medical writers to ensure accuracy. Our medical review team covers a wide range of medical specialities, with extensive experience in clinical practice, research, and patient advocacy.
We have strict sourcing guidelines and rely on peer-reviewed studies, academic research institutions, government agencies, and medical associations.
Every article is thoroughly researched, and sources are vetted to ensure they are recent, authoritative, and objective. Primary sources – including studies, scientific references, and statistics – are linked within each article or can be found in the sources section at the bottom of our articles.
MBChB – Bristol University (UK)
Dr. David Busby is a senior hospital clinician with extensive experience in general medicine, paediatrics, emergency and intensive care. He has special interests in public health, smoking cessation, telehealth and clinical systems. Dr. Busby is the Medical Director of Liber Pharmaceuticals.
PhD, Genetics, Genomics, Integrated Toxicology & Environmental Health – Duke University (USA) | BSc. Biology, Psychology – University of Oregon (USA)
Dr. Autumn Bernal is the Founder & Principle Scientist at ToxCreative, LLC. Dr. Bernal is a toxicologist with over 15 years of experience in toxicology study design, exposure assessment, and human health risk assessment. Her focal areas include safety assessments for product development and integration of non-clinical and clinical studies to evaluate potential human health risk. Dr. Bernal has provided consulting services to Liber Pharmaceuticals.